SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-23-005568
Filing Date
2023-12-18
Accepted
2023-12-18 11:45:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3526
  Complete submission text file 0001959173-23-005568.txt   5361
Mailing Address 221 CRESCENT STREET BLDG. 17, SUITE 401 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BLDG. 17, SUITE 401 WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Subject) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1215
Type: 144 | Act: 33 | File No.: 001-36483 | Film No.: 231492694
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O VIRIDIAN THERAPEUTICS, INC. 203 CRESCENT STREET, BLDG. 17, SUITE 102 WALTHAM MA 02453
Business Address
Meisner Lara (Reporting) CIK: 0001883986 (see all company filings)

Type: 144